These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 31046824)

  • 1. Low plasma concentrations of apolipoprotein M are associated with disease activity and endothelial dysfunction in systemic lupus erythematosus.
    Tydén H; Lood C; Jönsen A; Gullstrand B; Kahn R; Linge P; Kumaraswamy SB; Dahlbäck B; Bengtsson AA
    Arthritis Res Ther; 2019 May; 21(1):110. PubMed ID: 31046824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low apolipoprotein M serum levels correlate with Systemic lupus erythematosus disease activity and apolipoprotein M gene polymorphisms with Lupus.
    Du W; Shen T; Li H; Liu Y; He L; Tan L; Hu M; Ren Y
    Lipids Health Dis; 2017 May; 16(1):88. PubMed ID: 28476116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Association of serum level of apolipoprotein M with disease activity in systemic lupus erythematosus].
    DU W; Wang L; Li H; Liu Y; Shen T; Hu M
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Apr; 40(4):367-72. PubMed ID: 25931215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein M in patients with chronic kidney disease.
    Sørensen IM; Bertelsen M; Freese E; Lindhard K; Ullum H; Feldt-Rasmussen B; Nielsen LB; Christoffersen C; Bro S
    Atherosclerosis; 2018 Aug; 275():304-311. PubMed ID: 29980057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasculitis in systemic lupus erythematosus (SLE)--assessment of peripheral blood mononuclear cell activation and the degree of endothelial dysfunction: initial report.
    Kluz J; Kopeć W; Jakobsche U; Prajs I; Adamiec R
    Postepy Hig Med Dosw (Online); 2007 Dec; 61():725-35. PubMed ID: 18063917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of lipid metabolism including serum apolipoprotein M levels in patients with primary nephrotic syndrome.
    He L; Wu P; Tan L; Le B; Du W; Shen T; Wu J; Xiang Z; Hu M
    Lipids Health Dis; 2017 Sep; 16(1):167. PubMed ID: 28877724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased plasma concentrations of apolipoprotein M in sepsis and systemic inflammatory response syndromes.
    Kumaraswamy SB; Linder A; Åkesson P; Dahlbäck B
    Crit Care; 2012 Dec; 16(2):R60. PubMed ID: 22512779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating endothelial cells, endothelial apoptosis and soluble markers of endothelial dysfunction in patients with systemic lupus erythematosus-related vasculitis.
    Kluz J; Kopeć W; Jakobsche-Policht U; Adamiec R
    Int Angiol; 2009 Jun; 28(3):192-201. PubMed ID: 19506538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum high-density lipoprotein correlates with serum apolipoprotein M and A5 in obstructive sleep apnea hypopnea syndrome.
    Tan S; Liu X; Xu Y; Luo L; Zhou S; Gao Y
    Sleep Breath; 2017 Mar; 21(1):37-44. PubMed ID: 27206623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased serum thrombospondin-1 and elevation of its autoantibody are associated with multiple exacerbated clinical manifestations in systemic lupus erythematosus.
    Meng Y; Zhang M; Zhao X; Cheng Y; Jia R; Wang Y; Sun X
    Clin Rheumatol; 2018 Oct; 37(10):2707-2714. PubMed ID: 29998369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of serum inflammatory cytokines with anemia and vascular endothelial function in children with systemic lupus erythematosus.
    Yang Y; Che Y; Yang L
    Clin Hemorheol Microcirc; 2019; 73(2):299-306. PubMed ID: 30909195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stable Isotope Kinetic Study of ApoM (Apolipoprotein M).
    Croyal M; Billon-Crossouard S; Goulitquer S; Aguesse A; León L; Fall F; Chétiveaux M; Moyon T; Blanchard V; Ouguerram K; Lambert G; Nobécourt E; Krempf M
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):255-261. PubMed ID: 29146748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum free light chains as biomarkers for systemic lupus erythematosus disease activity.
    Aggarwal R; Sequeira W; Kokebie R; Mikolaitis RA; Fogg L; Finnegan A; Plaas A; Block JA; Jolly M
    Arthritis Care Res (Hoboken); 2011 Jun; 63(6):891-8. PubMed ID: 21312346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCL13 is an activity marker for systemic, but not cutaneous lupus erythematosus: a longitudinal cohort study.
    Niederkorn A; Frühauf J; Schwantzer G; Wutte N; Painsi C; Werner S; Stradner M; Berghold A; Hermann J; Aberer E
    Arch Dermatol Res; 2018 Aug; 310(6):485-493. PubMed ID: 29728857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum DNase I activity in systemic lupus erythematosus: correlation with immunoserological markers, the disease activity and organ involvement.
    Skiljevic D; Jeremic I; Nikolic M; Andrejevic S; Sefik-Bukilica M; Stojimirovic B; Bonaci-Nikolic B
    Clin Chem Lab Med; 2013 May; 51(5):1083-91. PubMed ID: 23183758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematocrit Level could Reflect Inflammatory Response and Disease Activity in Patients with Systemic Lupus Erythematosus.
    Yang M; Ma N; Fu H; Wei T; Tang Q; Qin B; Yang Z; Zhong R
    Clin Lab; 2015; 61(7):801-7. PubMed ID: 26299080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-apolipoprotein A-1 autoantibodies correlate with disease activity in systemic lupus erythematosus.
    Nigolian H; Ribi C; Courvoisier DS; Pagano S; Alvarez M; Trendelenburg M; Huynh-Do U; Vuilleumier N; Dayer JM; Chizzolini C; Roux-Lombard P
    Rheumatology (Oxford); 2020 Mar; 59(3):534-544. PubMed ID: 31377780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IFNα and its response proteins, IP-10 and SIGLEC-1, are biomarkers of disease activity in systemic lupus erythematosus.
    Rose T; Grützkau A; Hirseland H; Huscher D; Dähnrich C; Dzionek A; Ozimkowski T; Schlumberger W; Enghard P; Radbruch A; Riemekasten G; Burmester GR; Hiepe F; Biesen R
    Ann Rheum Dis; 2013 Oct; 72(10):1639-45. PubMed ID: 23117242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiopoietin-2, endothelial dysfunction and renal involvement in patients with systemic lupus erythematosus.
    El-Banawy HS; Gaber EW; Maharem DA; Matrawy KA
    J Nephrol; 2012; 25(4):541-50. PubMed ID: 21956768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-32γ: Possible association with the activity and development of nephritis in patients with systemic lupus erythematosus.
    Kwon OC; Ghang B; Lee EJ; Hong S; Lee CK; Yoo B; Kim S; Kim YG
    Int J Rheum Dis; 2019 Jul; 22(7):1305-1311. PubMed ID: 30941928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.